354- 59% of COVID-19 patients developed sepsis, 20% developed septic shock, and 15% developed secondary infection.
U.S. and International Patents and Patents Pending. © 2025 Swan Valley Medical, Incorporated. All Rights Reserved. T-SPeC® and the Swan icon are registered trademarks of Swan Valley Medical, Incorporated.